✦ LIBER ✦

Bromocriptine monotherapy: potential in Parkinson’s disease

Book ID: 120875567
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 1997
Weight: 203 KB
Volume: &NA;
Category: Article
ISSN: 1173-8324
DOI: 10.2165/00128413-199711150-00018

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Tolcapone, bromocriptine, and Parkinson'

Tolcapone, bromocriptine, and Parkinson's disease

✍ Y Agid; A Destée; F Durif; J-L Montastruc; P Pollak on behalf of the French Tolc 📂 Article 📅 1997 🏛 The Lancet 🌐 English ⚖ 56 KB

Visual evoked potentials in Parkinson's

Visual evoked potentials in Parkinson's disease before and after bromocriptine treatment

✍ A. Rossi; A. Picchiarelli; R. Fausti; M. Zampolini; G. Campocchi 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 123 KB

Bromocriptine reduces levodopa consumpti

Bromocriptine reduces levodopa consumption in Parkinson’s disease

📂 Article 📅 1997 🏛 Adis International Limited (now part of Wolters Kl ⚖ 194 KB

Rotigotine monotherapy in early parkinso

Rotigotine monotherapy in early parkinson’s disease

✍ John C. Morgan; Kapil D. Sethi 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 112 KB

Dopamine agonist monotherapy in Parkinso

Dopamine agonist monotherapy in Parkinson's disease

✍ CE Clarke; M Guttman 📂 Article 📅 2002 🏛 The Lancet 🌐 English ⚖ 221 KB

Bromocriptine and lisuride in Parkinson

Bromocriptine and lisuride in Parkinson disease

✍ Dr Abraham N. Lieberman; Govindan Gopinathan; Andreas Neophytides; Morton Leibow 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 English ⚖ 375 KB 👁 2 views

The authors wish to thank Eileen Boyd, R N , Clare Strohsahl, RN, Bernadette Hargin, RN, and the staff of 1 0 East for their help in evaluating the patients, and Kathleen Faridazar, MA, for help in preparing the manuscript.